EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Cytosolic Versus Lysosomal Lipolysis in Adipose Tissue: Opposing Roles in Cardiometabolic Disease

Yu-Sheng Yeh iD, Jun Huang iD, Ziyang Liu, Carlos Cosme, Xiangyu Zhang, Babak Razani iD

Arteriosclerosis, Thrombosis, and Vascular Biology · 2026

DOI: 10.1161/atvbaha.125.323273 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2026. Verfasst von Yu-Sheng Yeh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Vascular Medicine Institute, University of Pittsburgh School of Medicine and UPMC, PA (Y.-S.Y., J.H., Z.L., C.C., X.Z., B.…. Hauptthemen laut MEDLINE: Lipolysis, Lysosomes, Cytosol, Adipose Tissue. Die Arbeit nennt 100 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adipose tissue lipid metabolism is a critical regulator of systemic energy balance, but its impact on cardiometabolic health is paradoxical. This review dissects the 2 primary lipolytic systems in adipocytes: the canonical cytosolic pathway driven by ATGL/PNPLA2 (adipose triglyceride lipase) and the lysosomal pathway governed by LAL/LIPA (lysosomal acid lipase). We present emerging evidence that these pathways exert opposing effects in the context of obesity. While excessive fatty acid efflux from dysregulated cytosolic lipolysis is a known driver of adiposopathic dyslipidemia, adipose inflammation, and direct cardiac lipotoxicity, which collectively impair cardiometabolic health, the activity of the lysosomal pathway is emerging as a protective counterbalance. Genetic and pharmacological studies demonstrate that inhibiting cytosolic ATGL is beneficial for metabolic health, whereas enhancing LAL-mediated lipolysis mitigates obesity-related dysfunction. This functional antagonism between cytosolic and lysosomal lipolysis presents a new paradigm in lipid metabolism, suggesting that therapeutic strategies must be pathway-specific. We conclude that selectively inhibiting pathogenic cytosolic lipid release while promoting beneficial lysosomal lipid processing offers a nuanced approach to treating metabolic disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipolysisLysosomesCytosolAdipose TissueObesityAdipocytesCardiovascular DiseasesMetabolic DiseasesHumansAnimalsLipaseSterol EsteraseSignal TransductionEnergy MetabolismAcyltransferases

Stichwörter der Autor:innen

adipose tissuecardiovascular diseaseslipid metabolismlipolysislysosomal acid lipasemetabolic diseasesobesity

Substanzen

LipaseSterol EsterasePNPLA2 protein, humanAcyltransferases

Autor:innen und Institutionen

  • Department of Medicine and Vascular Medicine Institute, University of Pittsburgh School of Medicine and UPMC, PA (Y.-S.Y., J.H., Z.L., C.C., X.Z., B.R.).
  • Pittsburgh VA Medical Center, PA (Y.-S.Y., J.H., Z.L., X.Z., B.R.).

ORCID-Profile: Yu-Sheng Yeh, Jun Huang, Babak Razani

Förderung

  • NHLBI NIH HHS
  • NIDDK NIH HHS
  • NIGMS NIH HHS
  • BLRD VA

Zitieren

APA

Yeh, Y. S., Huang, J., Liu, Z., Cosme, C., Zhang, X., & Razani, B. (2026). Cytosolic Versus Lysosomal Lipolysis in Adipose Tissue: Opposing Roles in Cardiometabolic Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.125.323273

Vancouver

Yeh YS, Huang J, Liu Z, Cosme C, Zhang X, Razani B. Cytosolic Versus Lysosomal Lipolysis in Adipose Tissue: Opposing Roles in Cardiometabolic Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 2026. doi:10.1161/atvbaha.125.323273

BibTeX
@article{Yeh2026,
  author = {Yeh, Yu-Sheng and Huang, Jun and Liu, Ziyang and Cosme, Carlos and Zhang, Xiangyu and Razani, Babak},
  title = {Cytosolic Versus Lysosomal Lipolysis in Adipose Tissue: Opposing Roles in Cardiometabolic Disease},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2026},
  doi = {10.1161/atvbaha.125.323273}
}
Kostenlos starten →